
Opinion|Videos|April 16, 2024
Assessing the Cost-Effectiveness of Prescription Digital Therapeutics
Mahsa Salsabili, PharmD, PhD, underscores the potential cost-effectiveness of treatment through the adoption of prescription digital therapeutics, while acknowledging that additional evidence is required to conclusively determine their cost-effectiveness.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers discover new pathway to fight liver inflammation
2
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
3
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
4
FDA approves $2.7 million gene therapy for rare metabolic disorder
5




















